A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy
Clinical trial NCT03167203 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT03167203
- Sponsor
- Astellas Institute for Regenerative Medicine
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-08
- Primary completion
- 2029-03-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.